PTG
  • Home
  • Research
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
  • Job offers
  • About

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis

5/25/2018

 
Background:  
Anti-human leukocyte antigen donor-specific antibodies (anti-HLA DSAs) are recognized as a major barrier to patients’ access to organ transplantation and the major cause of graft failure. The capacity of circulating anti-HLA DSAs to activate complement has been suggested as a potential biomarker for optimizing graft allocation and improving the rate of successful transplantations.
Methods and findingsTo address the clinical relevance of complement-activating anti-HLA DSAs across all solid organ transplant patients, we performed a meta-analysis of their association with transplant outcome through a systematic review, from inception to January 31, 2018. The primary outcome was allograft loss, and the secondary outcome was allograft rejection. A comprehensive search strategy was conducted through several databases (Medline, Embase, Cochrane, and Scopus).
A total of 5,861 eligible citations were identified. A total of 37 studies were included in the meta-analysis. Studies reported on 7,936 patients, including kidney (n = 5,991), liver (n = 1,459), heart (n = 370), and lung recipients (n = 116). Solid organ transplant recipients with circulating complement-activating anti-HLA DSAs experienced an increased risk of allograft loss (pooled HR 3.09; 95% CI 2.55–3.74, P = 0.001; I2 = 29.3%), and allograft rejection (pooled HR 3.75; 95% CI: 2.05–6.87, P = 0.001; I2 = 69.8%) compared to patients without complement-activating anti-HLA DSAs. The association between circulating complement-activating anti-HLA DSAs and allograft failure was consistent across all subgroups and sensitivity analyses. Limitations of the study are the observational and retrospective design of almost all included studies, the higher proportion of kidney recipients compared to other solid organ transplant recipients, and the inclusion of fewer studies investigating allograft rejection.
ConclusionsIn this study, we found that circulating complement-activating anti-HLA DSAs had a significant deleterious impact on solid organ transplant survival and risk of rejection. The detection of complement-activating anti-HLA DSAs may add value at an individual patient level for noninvasive biomarker-guided risk stratification.
Picture
Picture
Picture
Cit: Antoine Bouquegneau et al.  PLoS Med. 2018 May 25;15(5):e1002572. PMID: 30052664

Comments are closed.

    Paris Transplant Group

    Our global aim is to accelerate the translation of immunological and gene expression discoveries into the clinical field by filling the gap between basic science and applied biomedical researches.

    CATEGORIES

    Awards
    Events
    Job offers
    Press Releases
    Publications

    ALl

    All
    Alexandre Loupy
    Antoine Bouquegneau
    Antoine Durrbach
    Antoine Roux
    Awards
    Carmen Lefaucheur
    Charlotte Loheac
    Christophe Legendre
    Dany Anglicheau
    Denis Glotz
    Denis Viglietti
    Elodie Bailly
    Events
    Gillian Divard
    Guillaume Bonnet
    Guillaume Coutance
    Jean Luc Taupin
    Jean Paul Duong Van Huyen
    Jean Philippe Empana
    Jean-Philippe Empana
    Job
    Juliette Gueguen
    Kevin Louis
    Marc Raynaud
    Maud Racape
    Michel Delahousse
    Olivier Aubert
    Patrick Bruneval
    Peter Reese
    Press Releases
    Publications
    Xavier Jouven
    Yassine Bouatou

    Archives

    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    March 2019
    February 2019
    December 2018
    September 2018
    May 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    June 2016
    April 2016
    October 2015
    June 2015
    August 2014
    January 2014
    September 2013
    January 2013
    June 2011
    August 2010
    May 2009

    RSS Feed

Research

PTG Research
PTG Publications
Technical platforms​
Database resources

Partnerships

Research collaborations
Technical platforms
​Database access
​

Paris Transplant Group

About PTG
PTG Team
​​Careers at PTG
​
Latest news
​Contact us
LEGAL NOTICE AND PRIVACY POLICY
© COPYRIGHT 2019. ALL RIGHTS RESERVED.

 LABS EXPLORER for the PARIS TRANSPLANT GROUP.
  • Home
  • Research
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
  • Job offers
  • About